|
Jul 23
|
Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025
|
|
Jul 15
|
Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions
|
|
Jul 12
|
Leerink Partners Reiterates a Buy Rating on Wave Life Sciences (WVE), Keeps the PT at $24
|
|
Jul 3
|
H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release
|
|
May 29
|
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
|
|
May 28
|
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
|
|
Feb 19
|
What Makes Wave Life Sciences Ltd. (WVE) an Investment Bet?
|